Acorah Software Products - Accounts Production 16.3.350 false true 31 October 2023 1 November 2022 false 1 November 2023 31 October 2024 31 October 2024 13657783 Mr S Kalra Mrs R V Kalra iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 13657783 2023-10-31 13657783 2024-10-31 13657783 2023-11-01 2024-10-31 13657783 frs-core:CurrentFinancialInstruments 2024-10-31 13657783 frs-core:ShareCapital 2024-10-31 13657783 frs-core:RetainedEarningsAccumulatedLosses 2024-10-31 13657783 frs-bus:PrivateLimitedCompanyLtd 2023-11-01 2024-10-31 13657783 frs-bus:FilletedAccounts 2023-11-01 2024-10-31 13657783 frs-bus:SmallEntities 2023-11-01 2024-10-31 13657783 frs-bus:AuditExempt-NoAccountantsReport 2023-11-01 2024-10-31 13657783 frs-bus:SmallCompaniesRegimeForAccounts 2023-11-01 2024-10-31 13657783 frs-bus:Director1 2023-11-01 2024-10-31 13657783 frs-bus:CompanySecretary1 2023-11-01 2024-10-31 13657783 frs-countries:EnglandWales 2023-11-01 2024-10-31 13657783 2022-10-31 13657783 2023-10-31 13657783 2022-11-01 2023-10-31 13657783 frs-core:CurrentFinancialInstruments 2023-10-31 13657783 frs-core:ShareCapital 2023-10-31 13657783 frs-core:RetainedEarningsAccumulatedLosses 2023-10-31
Registered number: 13657783
Kalra Medical Services Ltd
Unaudited Financial Statements
For The Year Ended 31 October 2024
Contents
Page
Company Information 1
Balance Sheet 2
Notes to the Financial Statements 3—4
Page 1
Company Information
Director Mr S Kalra
Secretary Mrs R V Kalra
Company Number 13657783
Registered Office Hanover Buildings
11-13 Hanover Street
Liverpool
Merseyside
L1 3DN
Accountants ERC Accountants & Business Advisers Limited
Chartered Accountants
Hanover Buildings, 11-13 Hanover Street
Liverpool
Merseyside
L1 3DN
Page 1
Page 2
Balance Sheet
Registered number: 13657783
2024 2023
Notes £ £ £ £
CURRENT ASSETS
Cash at bank and in hand 172,163 120,591
172,163 120,591
Creditors: Amounts Falling Due Within One Year 4 (23,877 ) (34,176 )
NET CURRENT ASSETS (LIABILITIES) 148,286 86,415
TOTAL ASSETS LESS CURRENT LIABILITIES 148,286 86,415
NET ASSETS 148,286 86,415
CAPITAL AND RESERVES
Called up share capital 5 2 2
Profit and Loss Account 148,284 86,413
SHAREHOLDERS' FUNDS 148,286 86,415
For the year ending 31 October 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Mr S Kalra
Director
28 April 2025
The notes on pages 3 to 4 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
Kalra Medical Services Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 13657783 . The registered office is Hanover Buildings, 11-13 Hanover Street, Liverpool, Merseyside, L1 3DN.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.

The financial statements are prepared in sterling, which is the functional currency of the entity.

These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
2.2. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.
Rendering of services
Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
2.3. Taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively.

Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2023: 1)
1 1
4. Creditors: Amounts Falling Due Within One Year
2024 2023
£ £
Corporation tax 17,513 13,193
Accruals and deferred income 2,464 1,859
Director's loan account 3,900 19,124
23,877 34,176
5. Share Capital
2024 2023
£ £
Allotted, Called up and fully paid 2 2
Page 3
Page 4
6. Related Party Transactions
The following related party transactions were undertaken during the year:
The director introduced funds totalling £16,770 (2023: £5,580), was issued dividends of £1,000 (2023: £2,000) and withdrew funds totalling £32,994 (2023: £5,000). At the balance sheet date the amount owed to the director was £3,900 (2023: £19,124).
Dividends were paid to the shareholders in respect of their shareholdings totalling £1,000 (2023: £2,000).
The aggregate remuneration paid to key management personnel for the year was £Nil.
No further transactions with related parties were undertaken such as are required to be disclosed in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
Page 4